Parkinson’s Disease (PD) is often treated with dopamine agonist medications that are effective at relieving symptoms of the disease. However, in some PD patients, these medications can lead to the development of gambling-related problems. One alternative treatment for PD is deep brain stimulation (DBS) of a part of the brain called the subthalamic nucleus (STN), which plays a role in movement and decision-making. This leads to concerns that using DBS in the STN will alter decision-making and itself cause problematic gambling behavior. To investigate this possibility, Wendy Adams and her colleagues conducted a study that tested whether STN-DBS in rats changes their performance on a test of decision-making skills designed for rats – the rat Gambling Task (rGT). This week, The WAGER reviews their work.
What was the research question?
Does STN-DBS alter the decision-making ability of rats on the rGT?
What did the researchers do?
The researchers trained 24 male rats to perform the rGT, which is based on a test that measures decision-making in humans – the Iowa Gambling Task. In the rGT, hungry rats are allowed a choice of four response holes to poke their nose in as many times as they can for 30 minutes to try and get the most sugar pellets. Each nose-poke will either result in a win (sugar pellets appear in the food tray) or a loss (a time-out punishment). Some holes are safer bets than others; Hole 2 (the optimal choice) might provide only two pellets on a win but has a low chance of a short time-out, whereas Hole 4 (the risky choice) might provide four pellets but a high chance of a long time-out. (See Figure.) At baseline, some rats (“optimal decision-makers”) learned to consistently choose Hole 2 and others rats preferred Holes 3 and 4 (“risky-decision makers”). The researchers then implanted electrodes in the STN of each rat and made them do the rGT again, ten times with the electrodes turned on (DBS condition), and three times with the electrodes turned off (mock DBS).
What did they find?
For rats who were optimal decision-makers at baseline, receiving STN-DBS during the rGT did not alter their performance on the task. However, for the rats who were naturally risky decision-makers at baseline, STN-DBS had a delayed but significant impact on their rGT performance – by the fourth session of rGT with DBS, these rats began to prefer choosing Hole 2, indicating that their decision-making had become less risky. After the STN-DBS was turned off, risky decision-making rats reverted back to their original performance on the rGT.
Why do these findings matter?
The finding that STN-DBS does not make decision-making more risky in rats suggests that this procedure might be a safe treatment for PD patients. In fact, STN-DBS appeared to selectively made decision-making safer in rats who had a natural tendency towards risky decision-making. As a recent BASIS reported, people with alcohol use disorder and people with gambling disorder both exhibit particularly risky decision-making on the IGT. This leads to an intriguing possibility: could STN-DBS one day become useful for treating addiction in humans?
Every study has limitations. What are the limitations in this study?
While STN-DBS selectively made decision-making less risky in risk-preferring male rats, it remains to be seen if the same effect will occur in female rats, let alone humans. Furthermore, the researchers ended up having to exclude data from seven of the rats (for reasons such as ill-health or the electrodes not being placed correctly), leaving only 13 optimal decision-makers and 4 risky decision-makers in their sample.
For more information:
Your First Step to Change: Gambling, 2nd Edition is a free self-help book for anyone concerned about their gambling behavior.
— Rhiannon Chou Wiley
What do you think? Please use the comment link below to provide feedback on this article.